Fetal vibroacoustic stimulation for facilitation of tests of fetal wellbeing: Cochrane systematic review

Abstract

Assessed as up to date: 2013/09/30

Background

Acoustic stimulation of the fetus has been suggested to improve the efficiency of antepartum fetal heart rate testing.

Objectives

To assess the advantages and disadvantages of the use of fetal vibroacoustic stimulation in conjunction with tests of fetal wellbeing.

Search methods

We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 September 2013).

Selection criteria

All published and unpublished randomised controlled trials assessing the merits of the use of fetal vibroacoustic stimulation in conjunction with tests of fetal wellbeing.

Data collection and analysis

All review authors independently extracted data and assessed trial quality. Authors of published and unpublished trials were contacted for further information.

Main results

Altogether 12 trials with a total of 6822 participants were included. Fetal vibroacoustic stimulation reduced the incidence of non-reactive antenatal cardiotocography test (nine trials; average risk ratio (RR) 0.62, 95% confidence interval (CI) 0.48 to 0.81). Vibroacoustic stimulation compared with mock stimulation evoked significantly more fetal movements when used in conjunction with fetal heart rate testing (one trial, RR 0.23, 95% CI 0.18 to 0.29).

Authors' conclusions

Vibroacoustic stimulation offers benefits by decreasing the incidence of non-reactive cardiotocography and reducing the testing time. Further randomised trials should be encouraged to determine not only the optimum intensity, frequency, duration and position of the vibroacoustic stimulation, but also to evaluate the efficacy, predictive reliability, safety and perinatal outcome of these stimuli with cardiotocography and other tests of fetal wellbeing.

Author(s)

Tan Kelvin H, Smyth Rebecca MD, Wei Xing

Summary

Fetal vibroacoustic stimulation for facilitation of tests of the wellbeing of the unborn baby

Acoustic stimulation of unborn babies may make tests on their wellbeing more effective.

Tests on unborn babies such as ultrasound, measuring the number of movements and the heart rate are carried out to check the baby’s wellbeing. As a baby's sleep periods can alter these results by making it non-reactive, various methods are used to wake the baby so that it can respond to the stimulus. Fetal vibroacoustic stimulation uses a hand-held electronic device placed just above the pregnant woman's abdomen. Brief sounds are sent through the mother’s abdomen to her baby. The vibroacoustic stimulation gives the opportunity to assess how the baby responds. Exposure of the baby to the vibroacoustic stimulation is generally considered safe but it can cause vigorous fetal movements and fetal distress. 

This review of 12 randomised controlled trials involving 6822 mothers found that vibroacoustic stimulation improved the effectiveness of the baby's heart rate testing. However, the data on fetal distress and perinatal death were too few to draw any conclusions on safety. More research is needed to determine the optimal intensity, frequency, duration and position of the vibroacoustic stimulation and to evaluate the safety and perinatal outcomes when used with cardiotocography and other tests of fetal wellbeing.

Reviewer's Conclusions

Implications for practice

By reducing the number of non-reactive cardiotocography secondary to fetal sleep states and reducing the testing time, fetal vibroacoustic stimulation may help perinatal resources to be better utilised. By evoking fetal movements, fetal vibroacoustic stimulation may be useful in ultrasound examination and evaluation of fetal wellbeing.

However, due to the void in the literature of randomised controlled trials relating to important outcomes such as fetal hearing impairment, impairment of neurological development, maternal satisfaction and maternal anxiety, and perinatal mortality, there is still currently insufficient evidence within randomised controlled trials based upon which a firm recommendation regarding the routine use of fetal vibroacoustic stimulation can be made.

Implications for research

More randomised studies are needed to define the role of fetal vibroacoustic stimulations in obstetrics. In particular, further randomised trials should be encouraged to determine not only the optimum intensity, frequency, duration and position of the vibroacoustic stimulation, but also to evaluate the efficacy, safety and perinatal outcome of these stimuli in conjunction with cardiotocography and other tests of fetal wellbeing.

Given the large number of excluded studies, future trials should not only be of high quality but need to report outcomes of clinical relevance. There was only one trial in which the comparison was with mock stimulation. It would be good to encourage more blinded studies with mock stimulation to ensure higher quality trials. Trials with outcomes such as fetal hearing impairment, impaired neurological development, maternal satisfaction and maternal anxiety should also be encouraged.

Get full text at The Cochrane Library

Fetal vibroacoustic stimulation for facilitation of tests of fetal wellbeing: Cochrane systematic review is a sample topic from the Cochrane Abstracts.

To view other topics, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Learn more.

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Fetal vibroacoustic stimulation for facilitation of tests of fetal wellbeing: Cochrane systematic review ID - 434132 BT - Cochrane Abstracts UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434132/all/Fetal_vibroacoustic_stimulation_for_facilitation_of_tests_of_fetal_wellbeing:_Cochrane_systematic_review DB - Evidence Central DP - Unbound Medicine ER -